Can leukemia-derived dendritic cells generate antileukemia immunity?
about
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias.PR1 vaccination in myeloid malignancies.Peptide vaccine therapy for leukemia.Bioactivity of umbilical cord blood dendritic cells and anti-leukemia effect.Histone deacetylase inhibition improves differentiation of dendritic cells from leukemic blasts of patients with TEL/AML1-positive acute lymphoblastic leukemia.
P2860
Can leukemia-derived dendritic cells generate antileukemia immunity?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Can leukemia-derived dendritic cells generate antileukemia immunity?
@ast
Can leukemia-derived dendritic cells generate antileukemia immunity?
@en
type
label
Can leukemia-derived dendritic cells generate antileukemia immunity?
@ast
Can leukemia-derived dendritic cells generate antileukemia immunity?
@en
prefLabel
Can leukemia-derived dendritic cells generate antileukemia immunity?
@ast
Can leukemia-derived dendritic cells generate antileukemia immunity?
@en
P2860
P356
P1476
Can leukemia-derived dendritic cells generate antileukemia immunity?
@en
P2093
David Avigan
Jacalyn Rosenblatt
P2860
P304
P356
10.1586/14760584.5.4.467
P577
2006-08-01T00:00:00Z